Jork, Germany

Chris Meier

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Chris Meier

Introduction

Chris Meier is a notable inventor based in Jork, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs. With a total of four patents to his name, Meier's work focuses on improving the efficacy of nucleoside diphosphate and triphosphate prodrugs.

Latest Patents

One of his latest patents involves di- and triphosphate prodrugs. These compounds can be utilized as prodrugs, specifically targeting nucleoside diphosphate and triphosphate prodrugs. The aim of this invention is to provide enhanced di- and/or triphosphate prodrugs, particularly nucleotide or nucleotide analog prodrugs. This is achieved by bioreversibly and asymmetrically masking di- and triphosphate compounds, focusing on the terminal phosphate while omitting the masking of the internal phosphate. Another significant patent is a method for the solid phase-based production of phosphate-bridged nucleoside conjugates. This method begins with the production of a cyclosaligenyl nucleotide, followed by the addition of a linker for immobilization on a solid phase. A subsequent reaction with nucleophiles results in the desired phosphate-bridged nucleoside conjugates, which can then be cleaved from the solid phase-bound linker.

Career Highlights

Chris Meier has worked at prestigious institutions such as Universität Hamburg. His experience in these academic environments has contributed to his innovative research and development in the pharmaceutical field.

Collaborations

Throughout his career, Meier has collaborated with notable colleagues, including Jens O Thomann and Tristan Gollnest. These partnerships have likely enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

Chris Meier's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work on prodrugs and nucleoside conjugates highlights the importance of research in developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…